COMMUNIQUÉS West-GlobeNewswire

Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering
17/06/2025
HANOVER, Md., June 17, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (the “Company”), a clinical-stage pharmaceutical company developing Next Generation Cancer (NGC) therapies, today announced [...]
Precision Neuroscience Named to Fast Company’s World Changing Ideas and Inc.’s Best Workplaces Lists
17/06/2025
Awards recognize innovation in healthcare technology and excellence in workplace culture NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a leader in brain–computer interface ( [...]
Compass Health announces 2025 board of directors, bringing together accomplished leaders from regional, industry and nonprofit sectors
17/06/2025
EVERETT, Wash., June 17, 2025 (GLOBE NEWSWIRE) -- Today, Compass Health unveiled its 2025 board of directors, welcoming new members with expertise ranging from art therapy and healthcare marketing to strategic [...]
Slimjaro: Examining the Science and Safety of a Legal Slim Jaro Weight loss Health Formula
17/06/2025
Jacksonville, FL, June 17, 2025 (GLOBE NEWSWIRE) -- Weight loss is a humongous challenge that many people struggle with. Lack of motivation to continue a healthy lifestyle, diet, exercise, and hormonal imbalance, pave [...]
Endogenex to Present Data on Endoscopic Procedure for Type 2 Diabetes at American Diabetes Association’s (ADA) 85th Scientific Sessions
17/06/2025
MINNEAPOLIS, June 17, 2025 (GLOBE NEWSWIRE) -- Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), will present results from its REGENT-1 [...]
Communiqué de presse : Sanofi place 1,5 milliard d’euros d’emprunts obligataires
17/06/2025
Sanofi place 1,5 milliard d’euros d’emprunts obligataires Paris, 17 juin 2025 - Sanofi annonce avoir placé avec succès une émission obligataire en 2 tranches (les « obligations ») pour un montant de 1,5 milliard d’euros [...]
Press release: Sanofi successfully prices €1.5 billion bond issue
17/06/2025
Sanofi successfully prices €1.5 billion bond issue Paris, June 17, 2025 - Sanofi announces that it has successfully priced its offering of €1.5 billion of notes across 2 tranches: €750 million fixed-rate notes, due June [...]
Aptose Provides Corporate Updates
17/06/2025
Announces short-term cash advance SAN DIEGO and TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“ Aptose ” or the “ Company ”) (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company, [...]
Saudi Arabia Introduces Strategic Healthcare Vision and Global Partnerships at BIO 2025
17/06/2025
BOSTON, June 17, 2025 (GLOBE NEWSWIRE) -- Saudi Arabia officially opened its national pavilion today at the BIO International Convention 2025, marking a milestone moment in its journey to become a global biotechnology [...]
Adial Pharmaceuticals Announces Pricing of $3.6 Million Public Offering
17/06/2025
GLEN ALLEN, Va., June 17, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and [...]
Labviva Announces Key Executive Appointments to Drive Global Expansion
17/06/2025
Company scales leadership to accelerate growth and reinforce market position as the leader in AI-powered life sciences procurement BOSTON, June 17, 2025 (GLOBE NEWSWIRE) -- Labviva , the leading AI procurement platform [...]
AI. Robotics. Automation. DLH Technology and Innovation Powers Recently Honored Projects
17/06/2025
ATLANTA, June 17, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital [...]
SURGERY PARTNERS, INC. and Bain Capital Conclude Discussions
17/06/2025
-- Board reaffirms its confidence in the Company’s long-term growth prospects; Company reiterates full-year 2025 financial guidance Company expects to host an Investor Day in the second half of 2025 to discuss its [...]
Maxion Therapeutics Appoints Dr. Stefan Härtle as Chief Development Officer
17/06/2025
Cambridge, UK, 17 June 2025 – Maxion Therapeutics (“Maxion”), a biotechnology company developing antibody-based KnotBody® drugs for ion channel and G protein coupled receptor (GPCR)-driven diseases, today announces the [...]
Press Release Biocartis NV: Biocartis Welcomes Ben Svarczkopf as Senior Vice President of Global Marketing
17/06/2025
PRESS RELEASE - 06/17/2025, 07:00 AM CDT Biocartis Welcomes Ben Svarczkopf as Senior Vice President of Global Marketing Itasca (IL), United States - June 17, 2025. Biocartis Group of Companies (“Biocartis”), an [...]
Lisata Therapeutics and GATC Health Expand Relationship to Advance AI-Driven Drug Discovery and Development
17/06/2025
Expanded alliance combines Lisata’s drug development expertise with GATC’s AI-powered Multiomics Advanced Technology ® platform to accelerate and improve success rates of next-generation drug development Lisata to lead [...]
Elicio Therapeutics to Host Virtual KOL Event on June 25, 2025 to Discuss AMP-Powered ELI-002 for the Treatment of KRAS mutation-driven Pancreatic Cancer
17/06/2025
BOSTON, June 17, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of [...]
ORYZON to Attend the 2025 Phelan-McDermid Syndrome (PMS) Congress in Barcelona on June 26-29
17/06/2025
Oryzon’s CSO, Dr. Jordi Xaus, will participate in a Panel entitled “Industry Perspectives Discussion” on June 27 70-90% of PMS patients show autistic related features, including aggression Agitation/Aggression in PMS [...]
NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives
17/06/2025
CARMEL, Ind., June 17, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and [...]

Pages